(Q34625129)

3 August 2017

title

Extracellular vesicles as prospective carriers of oncogenic protein signatures in adult and paediatric brain tumours (English)

1 reference

extracellular vesicle in the nervous system

3 August 2017

main subject

1 reference

based on heuristic

inferred from title

extracellular vesicle

1 reference

2

Nada Jabado

0 references

Janusz Rak

series ordinal

3

object named as

Janusz Rak

1 reference

3 August 2017

Delphine Garnier

1

1 reference

3 August 2017

publication date

20 April 2013

1 reference

3 August 2017

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

10-11

1 reference

3 August 2017

page(s)

1595-1607

1 reference

Brain metastases as preventive and therapeutic targets

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

The molecular and genetic basis of neurological tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular biology of brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Malignant gliomas in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

The clinical implications of medulloblastoma subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Clonal selection drives genetic divergence of metastatic medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Brain tumor stem cells: bringing order to the chaos of brain cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Genetic alterations and signaling pathways in the evolution of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Paediatric and adult malignant glioma: close relatives or distant cousins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Extracellular vesicles--vehicles that spread cancer genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Membrane vesicles as conveyors of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Brain tumor microvesicles: insights into intercellular communication in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Vesicles associated with calcification in the matrix of epiphyseal cartilage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Quantitation of peroxidase-antibody binding to membrane fragments using column chromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Fate of the transferrin receptor during maturation of sheep reticulocytes in vitro: Selective externalization of the receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Ectosomes as modulators of inflammation and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Blood-borne tissue factor: another view of thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Exosomes: proteomic insights and diagnostic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Circulating microparticles: pathophysiology and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microvesicles: mediators of extracellular communication during cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Acid sphingomyelinase activity triggers microparticle release from glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

ExoCarta 2012: database of exosomal proteins, RNA and lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Protein targeting to exosomes/microvesicles by plasma membrane anchors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microglial microvesicle secretion and intercellular signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tissue factor-bearing microparticles and thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microparticle-associated tissue factor activity: a link between cancer and thrombosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tumor-derived tissue factor activates coagulation and enhances thrombosis in a mouse xenograft model of human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microvesicles: messengers and mediators of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteomic and immunologic analyses of brain tumor exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Oncogenic events regulate tissue factor expression in colorectal cancer cells: implications for tumor progression and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

The regulation of exosome secretion: a novel function of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Ceramide triggers budding of exosome vesicles into multivesicular endosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microfluidic isolation and transcriptome analysis of serum microvesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

CD44v6 dependence of premetastatic niche preparation by exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Endothelial progenitor cell derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microparticle-associated nucleic acids mediate trait dominance in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Translational research in brain metastasis is identifying molecular pathways that may lead to the development of new therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Targeting angiogenesis for treatment of NSCLC brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular aspects of breast cancer metastasis to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Genes that mediate breast cancer metastasis to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

A tell-tail sign of chromatin: histone mutations drive pediatric glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Glioma pathophysiology: insights emerging from proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Identification and validation of S100A7 associated with lung squamous cell carcinoma metastasis to brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteomic profiling of cerebrospinal fluid identifies prostaglandin D2 synthase as a putative biomarker for pediatric medulloblastoma: A pediatric brain tumor consortium study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Analysis of different medulloblastoma histotypes by two-dimensional gel and MALDI-TOF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Serum proteomics of glioma: methods and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Glycoproteomic analysis of glioblastoma stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Single-cell proteomic chip for profiling intracellular signaling pathways in single tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label-free quantification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Quantitative proteomic Isotope-Coded Protein Label (ICPL) analysis reveals alteration of several functional processes in the glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Biomarker discovery: a proteomic approach for brain cancer profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteomic identification of the wt-p53-regulated tumor cell secretome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteome analysis of microdissected tumor tissue using a capillary isoelectric focusing-based multidimensional separation platform coupled with ESI-tandem MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Molecular classification and survival prediction in human gliomas based on proteome analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteomic study of human glioblastoma multiforme tissue employing complementary two-dimensional liquid chromatography- and mass spectrometry-based approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

A human functional protein interaction network and its application to cancer data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Secretome signature of invasive glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Glioblastoma cell secretome: analysis of three glioblastoma cell lines reveal 148 non-redundant proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

A proteome comparison between physiological angiogenesis and angiogenesis in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Investigation of serum proteome alterations in human glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Quantitative phosphoproteomic analysis of the STAT3/IL-6/HIF1alpha signaling network: an initial study in GSC11 glioblastoma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Targeted tissue proteomic analysis of human astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Chemo-Resistant Protein Expression Pattern of Glioblastoma Cells (A172) to Perillyl Alcohol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Role of exosomes/microvesicles in the nervous system and use in emerging therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Exosome isolation for proteomic analyses and RNA profiling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Advances in membranous vesicle and exosome proteomics improving biological understanding and biomarker discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Circulating mutant DNA to assess tumor dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

New mechanism for Notch signaling to endothelium at a distance by Delta-like 4 incorporation into exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Higher-order oligomerization targets plasma membrane proteins and HIV gag to exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Medulloblastoma exosome proteomics yield functional roles for extracellular vesicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Large-scale proteomics and phosphoproteomics of urinary exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Proteomic analysis of exosomes from human neural stem cells by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Impact of pre-analytical parameters on the measurement of circulating microparticles: towards standardization of protocol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Leukocyte-versus microparticle-mediated tissue factor transfer during arteriolar thrombus development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Microvesicles Released from Human Renal Cancer Stem Cells Stimulate Angiogenesis and Formation of Lung Premetastatic Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPMIC.201200360

Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer

21 January 2018

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1038/NATURE11156

Identifiers

DOI

10.1002/PMIC.201200360

1 reference

3 August 2017

1 reference